Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00639769 Head and Neck C...
cisplatin
irinotecan hydr...
18 Years - Vanderbilt-Ingram Cancer Center View Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer NCT00040807 Head and Neck C...
docetaxel
irinotecan hydr...
18 Years - 120 Years Eastern Cooperative Oncology Group View Title XELOX FOR SALIVARY GLAND CANCERS NCT00101075 Head and Neck C...
Capecitabine
Oxaliplatin
18 Years - Dana-Farber Cancer Institute View Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors NCT00066651 Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI) View Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00006107 Head and Neck C...
Taxotere
Surgery
radiation thera...
18 Years - Dana-Farber Cancer Institute View Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00020189 Head and Neck C...
Thromboembolism
acetylsalicylic...
alvocidib
clopidogrel bis...
18 Years - National Cancer Institute (NCI) View Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00507767 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer NCT00482872 Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 Years Vanderbilt University Medical Center View S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00096512 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
sorafenib tosyl...
laboratory biom...
18 Years - National Cancer Institute (NCI) View DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer NCT00898664 Head and Neck C...
cytogenetic ana...
gene expression...
mutation analys...
polymerase chai...
immunohistochem...
laboratory biom...
18 Years - Vanderbilt-Ingram Cancer Center View Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases NCT00062348 Colorectal Canc...
Head and Neck C...
Metastatic Canc...
boronophenylala...
sodium borocapt...
conventional su...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC View EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer NCT00049140 Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University View Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck NCT02035527 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
sorafenib tosyl...
cisplatin
docetaxel
Correlative Stu...
18 Years - Ohio State University Comprehensive Cancer Center View Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer NCT00897793 Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
venipuncture
radiation thera...
18 Years - Vanderbilt-Ingram Cancer Center View Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma NCT00588770 Neck Squamous C...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Neck ...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Saliv...
Recurrent Sinon...
Salivary Gland ...
Stage IV Hypoph...
Stage IV Major ...
Stage IVA Laryn...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Major...
Stage IVA Oral ...
Stage IVA Oroph...
Stage IVA Sinon...
Stage IVB Laryn...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Major...
Stage IVB Oral ...
Stage IVB Oroph...
Stage IVB Sinon...
Stage IVC Laryn...
Stage IVC Laryn...
Stage IVC Lip a...
Stage IVC Major...
Stage IVC Oral ...
Stage IVC Oroph...
Stage IVC Sinon...
Tongue Carcinom...
Bevacizumab
Carboplatin
Cisplatin
Docetaxel
Fluorouracil
Laboratory Biom...
18 Years - National Cancer Institute (NCI) View EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer NCT00049140 Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University View Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer NCT00898742 Head and Neck C...
DNA and tissue ...
reverse transcr...
mass spectromet...
- Vanderbilt-Ingram Cancer Center View Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer NCT00003251 Drug/Agent Toxi...
Head and Neck C...
Radiation Toxic...
amifostine trih...
cisplatin
paclitaxel
radiation thera...
18 Years - National Cancer Institute (NCI) View Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck NCT00079053 Head and Neck C...
erlotinib hydro...
adjuvant therap...
18 Years - 120 Years Canadian Cancer Trials Group View Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery NCT00738868 Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI) View S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer NCT00337129 Head and Neck C...
eribulin mesyla...
18 Years - National Cancer Institute (NCI) View Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00507767 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer NCT00084435 Head and Neck C...
cisplatin
docetaxel
radiation thera...
18 Years - SWOG Cancer Research Network View Radiation Therapy in Treating Patients With Head and Neck Cancer NCT00021125 Head and Neck C...
Non-melanomatou...
adjuvant therap...
radiation thera...
- National Cancer Institute (NCI) View Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer NCT00004163 Head and Neck C...
Trastuzumab
18 Years - Dana-Farber Cancer Institute View Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy NCT00898430 Head and Neck C...
DNA Microarray ...
MALDI-TOF mass ...
DNA microarray ...
- Vanderbilt-Ingram Cancer Center View Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT00896675 Head and Neck C...
proteomic profi...
proteomic profi...
- Vanderbilt-Ingram Cancer Center View Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer NCT00899821 Head and Neck C...
aldesleukin
recombinant int...
sargramostim
immunologic tec...
biopsy
20 Years - 80 Years NYU Langone Health View Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00639769 Head and Neck C...
cisplatin
irinotecan hydr...
18 Years - Vanderbilt-Ingram Cancer Center View Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy NCT01156142 Head and Neck C...
Mucositis
Oral Complicati...
Pain
doxepin hydroch...
placebo
18 Years - Alliance for Clinical Trials in Oncology View Title XELOX FOR SALIVARY GLAND CANCERS NCT00101075 Head and Neck C...
Capecitabine
Oxaliplatin
18 Years - Dana-Farber Cancer Institute View Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery NCT00738868 Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI) View Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer NCT01313390 Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London View Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. NCT01469429 Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center View Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer NCT00114283 Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
lapatinib ditos...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Validation of a Screening Tool in Geriatric Oncology NCT00963911 Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Lymphoma
Prostate Cancer
Geriatric scree...
Multidimensiona...
70 Years - 120 Years Institut Bergonié View Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer NCT00004163 Head and Neck C...
Trastuzumab
18 Years - Dana-Farber Cancer Institute View Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer NCT00482872 Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 Years Vanderbilt University Medical Center View Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab NCT00939627 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
cetuximab
placebo
sorafenib tosyl...
laboratory biom...
quality-of-life...
18 Years - National Cancer Institute (NCI) View Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT00896675 Head and Neck C...
proteomic profi...
proteomic profi...
- Vanderbilt-Ingram Cancer Center View Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer NCT02245100 Metastatic Squa...
Salivary Gland ...
Stage IIIA Non-...
Stage IIIB Non-...
Stage IV Non-sm...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
Cytology specim...
Laboratory biom...
18 Years - Thomas Jefferson University View Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck NCT00906360 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Untreated Metas...
sunitinib malat...
pharmacological...
3-dimensional c...
cetuximab
18 Years - National Cancer Institute (NCI) View Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck NCT00081211 Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
PV701
18 Years - National Cancer Institute (NCI) View Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery NCT00003744 Head and Neck C...
gemcitabine
18 Years - Dana-Farber Cancer Institute View Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy NCT00559156 Head and Neck C...
arginine/omega-...
cisplatin
adjuvant therap...
radiation thera...
18 Years - National Cancer Institute (NCI) View Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma NCT00588770 Neck Squamous C...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Neck ...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Saliv...
Recurrent Sinon...
Salivary Gland ...
Stage IV Hypoph...
Stage IV Major ...
Stage IVA Laryn...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Major...
Stage IVA Oral ...
Stage IVA Oroph...
Stage IVA Sinon...
Stage IVB Laryn...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Major...
Stage IVB Oral ...
Stage IVB Oroph...
Stage IVB Sinon...
Stage IVC Laryn...
Stage IVC Laryn...
Stage IVC Lip a...
Stage IVC Major...
Stage IVC Oral ...
Stage IVC Oroph...
Stage IVC Sinon...
Tongue Carcinom...
Bevacizumab
Carboplatin
Cisplatin
Docetaxel
Fluorouracil
Laboratory Biom...
18 Years - National Cancer Institute (NCI) View S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer NCT00084435 Head and Neck C...
cisplatin
docetaxel
radiation thera...
18 Years - SWOG Cancer Research Network View Immunotoxin Therapy in Treating Patients With Advanced Cancer NCT00006981 Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI) View Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer NCT00003592 Head and Neck C...
methotrexate
paclitaxel
18 Years - 120 Years Eastern Cooperative Oncology Group View Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer NCT01313390 Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London View Family Quality of Life Among Families With a Member Who is a Cancer Patient NCT00544336 Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
Solid Tumor
questionnaire a...
survey administ...
quality-of-life...
21 Years - Vanderbilt-Ingram Cancer Center View Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT00896675 Head and Neck C...
proteomic profi...
proteomic profi...
- Vanderbilt-Ingram Cancer Center View Title XELOX FOR SALIVARY GLAND CANCERS NCT00101075 Head and Neck C...
Capecitabine
Oxaliplatin
18 Years - Dana-Farber Cancer Institute View Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00507767 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
dasatinib
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer NCT00098631 Metastatic Squa...
Recurrent Metas...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Untreated Metas...
lapatinib ditos...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer NCT00055770 Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
erlotinib hydro...
docetaxel
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI) View Immunotoxin Therapy in Treating Patients With Advanced Cancer NCT00006981 Cervical Cancer
Fallopian Tube ...
Head and Neck C...
Lung Cancer
Malignant Mesot...
Ovarian Cancer
Pancreatic Canc...
Primary Periton...
SS1(dsFv)-PE38 ...
18 Years - National Cancer Institute (NCI) View Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery NCT00738868 Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI) View Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck NCT00033618 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
ixabepilone
laboratory biom...
18 Years - National Cancer Institute (NCI) View Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection NCT01249443 HIV Infection
Recurrent Anal ...
Recurrent Breas...
Recurrent Esoph...
Recurrent Gastr...
Recurrent Metas...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Anal C...
Stage IV Breast...
Stage IV Esopha...
Stage IV Gastri...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Unspecified Adu...
vorinostat
diagnostic labo...
pharmacological...
carboplatin
paclitaxel
18 Years - AIDS Malignancy Consortium View Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00055913 Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Salivary Gland ...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
bevacizumab
erlotinib hydro...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer NCT00003592 Head and Neck C...
methotrexate
paclitaxel
18 Years - 120 Years Eastern Cooperative Oncology Group View Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy NCT01256385 Recurrent Hypop...
Recurrent Laryn...
Recurrent Laryn...
Recurrent Lip a...
Recurrent Metas...
Recurrent Nasal...
Recurrent Nasop...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Saliv...
Salivary Gland ...
Squamous Cell C...
Stage IV Hypoph...
Stage IV Nasoph...
Stage IVA Laryn...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Major...
Stage IVA Nasal...
Stage IVA Oral ...
Stage IVA Oroph...
Stage IVB Laryn...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Major...
Stage IVB Nasal...
Stage IVB Oral ...
Stage IVB Oroph...
Stage IVC Laryn...
Stage IVC Laryn...
Stage IVC Lip a...
Stage IVC Major...
Stage IVC Nasal...
Stage IVC Oral ...
Stage IVC Oroph...
Tongue Carcinom...
Cetuximab
Laboratory Biom...
Temsirolimus
18 Years - National Cancer Institute (NCI) View Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer NCT00004163 Head and Neck C...
Trastuzumab
18 Years - Dana-Farber Cancer Institute View Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. NCT01469429 Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center View Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia NCT00503776 Dysphagia
Head and Neck C...
Mucositis
Xerostomia
exercise interv...
amifostine trih...
therapeutic die...
21 Years - Vanderbilt-Ingram Cancer Center View Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer NCT01316757 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Untreated Metas...
cetuximab
paclitaxel
carboplatin
erlotinib hydro...
laboratory biom...
18 Years - Fox Chase Cancer Center View Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel NCT00003569 Head and Neck C...
Lung Cancer
Neurotoxicity
Ovarian Cancer
cisplatin
dimesna
paclitaxel
18 Years - Roswell Park Cancer Institute View Radiation Therapy in Treating Patients With Head and Neck Cancer NCT00021125 Head and Neck C...
Non-melanomatou...
adjuvant therap...
radiation thera...
- National Cancer Institute (NCI) View EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer NCT00049140 Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University View S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer NCT00337129 Head and Neck C...
eribulin mesyla...
18 Years - National Cancer Institute (NCI) View Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer NCT01847326 Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Tongue Cancer
carboplatin
paclitaxel albu...
fluorouracil
hydroxyurea
therapeutic con...
radiation thera...
hyperfractionat...
laboratory biom...
18 Years - University of Chicago View Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer NCT00024089 Head and Neck C...
gefitinib
18 Years - National Cancer Institute (NCI) View Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer NCT00020189 Head and Neck C...
Thromboembolism
acetylsalicylic...
alvocidib
clopidogrel bis...
18 Years - National Cancer Institute (NCI) View Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer NCT00022217 Head and Neck C...
carboplatin
cisplatin-e the...
paclitaxel
18 Years - National Cancer Institute (NCI) View Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer NCT00055770 Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
erlotinib hydro...
docetaxel
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI) View TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck NCT01334177 Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Saliva...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
TLR8 agonist VT...
cetuximab
laboratory biom...
pharmacogenomic...
18 Years - University of Washington View Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer NCT00003264 Head and Neck C...
cisplatin
gemcitabine hyd...
18 Years - Fox Chase Cancer Center View Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer NCT00024089 Head and Neck C...
gefitinib
18 Years - National Cancer Institute (NCI) View Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer NCT00058006 Head and Neck C...
Lung Cancer
celecoxib
adjuvant therap...
18 Years - Northwestern University View